TNXP
Tonix Pharmaceuticals Holding Corp
7.30$
-3.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.7% | -4.0% | -0.4% | -57.7% | -2.7% | -0.6% | -2.0% | -4.6% | +5.9% | +13.7% | +11.5% | – | |
| – | -2.0% | -17.0% | -31.8% | -10.1% | -13.9% | -1.3% | +61.3% | +26.5% | +0.4% | +9.0% | +14.5% | – | |
| – | -75.7% | +220.9% | +313.6% | -237.5% | – | -151.2% | – | -90.8% | +750.3% | -180.2% | – | – | |
| – | -75.8% | -75.3% | -98.4% | +410.5% | -66.7% | +100.0% | +42,216.7% | -60.0% | +84.5% | -9.7% | -65.3% | – | |
| – | – | – | – | -610.1% | -66.7% | +100.0% | +42,216.7% | -59.3% | -1.1% | +65.7% | -65.3% | – | |
| – | -100.0% | – | -100.0% | – | – | – | -4.8% | -98.3% | +16,290.5% | -100.0% | – | – | |
| – | – | – | – | – | +0.0% | +1,268.8% | -100.0% | – | – | – | – | – | |
| – | +548.9% | -100.5% | – | +510.7% | +98.5% | -41.8% | -77.8% | +811.5% | -41.0% | -65.8% | +65.8% | – | |
| – | – | -199.8% | – | – | +193.0% | -53.3% | -119.4% | – | -71.5% | -220.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.